-
14 Stocks That Are Gaining Momentum
Thursday, April 14, 2011 - 3:35pm | 188Its time for the weekly momentum gainers that you need to be keeping a close eye on. This week, there are about 14 stocks that have some intriguing appeal to them. One that is setting up nicely is Johnson & Johnson (JNJ), which bounced nicely off of its March lows, and looks to breakout once...
-
Perrigo Company Hits 52-Week High (PRGO)
Thursday, April 14, 2011 - 12:24pm | 33Perrigo Company (NASDAQ: PRGO) has hit a 52-week high in today's trading. At last check, the year-to-date performance of Perrigo Company is a gain of 38.5%.
-
Five-year Alemtuzumab Phase 2 Data Shows Large Percentage of MS Patients Remain Free of Clinically-Active Disease (SNY)
Thursday, April 14, 2011 - 12:03pm | 248Genzyme (NYSE: SNY), today reported additional five-year patient data from its completed Phase 2 multiple sclerosis trial showing that nearly two-thirds of alemtuzumab treated patients remained free of clinically-active disease as much as four years after most patients received their last course of...
-
Pharma News; BioSante Pharmaceuticals Reports Teva New Drug Application (NDA) for Testosterone Gel, Bio-T-Gel™
Thursday, April 14, 2011 - 11:28am | 766LINCOLNSHIRE, Ill. - April 13, 2011 (Investorideas.com newswire) - Pharma stock news; BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) reports a New Drug Application (NDA) has been accepted for filing by the U.S. Food and Drug Administration (FDA) following submission in January 2011 by a subsidiary...
-
Jazz Pharmaceuticals Hits 52-Week High (JAZZ)
Thursday, April 14, 2011 - 10:56am | 33Jazz Pharmaceuticals (NASDAQ: JAZZ) has hit a 52-week high in today's trading. At last check, the year-to-date performance of Jazz Pharmaceuticals is a gain of 73.8%.
-
GSK Says Announces Non-Core OTC Products To Be Divested -Bloomberg (GSK)
Thursday, April 14, 2011 - 10:10am | 18GlaxoSmithKline (NYSE: GSK) announces non-core otc products to be divested.
-
Shire Hits 52-Week High (SHPGY)
Thursday, April 14, 2011 - 10:06am | 31Shire (NASDAQ: SHPGY) has hit a 52-week high in today's trading. At last check, the year-to-date performance of Shire is a gain of 27.7%.
-
Top Percentage Gainers and Losers as of 10am 4/14/11(SVU, SIFY, JADE, WAVX, INVE, ABMD, TSTC, GFRE, FCS, ISTA)
Thursday, April 14, 2011 - 10:02am | 207Best 1) SuperValue (NYSE: SVU): Trading up 12.3% from yesterday's close to $10.23. The company reported better than expected Q4 EPS; $0.44 versus the $0.34 estimate. 2) Sify Technologies (NASDAQ: SIFY): Trading up 11.83% from yesterday's close to $6.05. Shares have gained 82.8% over the past 13...
-
Heska Names Executive Vice President (HSKA)
Thursday, April 14, 2011 - 9:06am | 68Heska Corporation (NASDAQ: HSKA) today announced that Joe Aperfine will be named Heska's Executive Vice President, Sales and Marketing. Mr. Aperfine is to join Heska from Banfield The Pet Hospital, the world's largest veterinary practice owner with over 780 hospitals and 13,000 employees, where he...
-
Teva Pharmaceutical Announces New Study Demonstrated Significant Reduction in Annualized Relapse Rate and Halting of Disability Progression in MS Patients Switching To Copaxone
Thursday, April 14, 2011 - 9:06am | 85Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today announced preliminary data from two studies, Coptimize and QualiCop. The global Coptimize study, which followed 688 patients from 19 countries, demonstrated that patients who switched to Copaxone from other approved disease modifying...
-
Benzinga's Top Upgrades (FRX, PTEN, CFNL, MG)
Thursday, April 14, 2011 - 8:24am | 137Forest Laboratories Inc (NYSE: FRX) was upgraded by Credit Suisse from "neutral" to "outperform." FRX's shares closed at $33.89 yesterday. Forest Laboratories' trailing-twelve-month operating margin is 26.83%. Global Hunter upgraded Patterson-UTI Energy Inc (NASDAQ: PTEN) from “accumulate” to “buy...
-
Citi Raises PT On ENDP
Thursday, April 14, 2011 - 8:19am | 76Citi has raised its price target from $42 to $48 on Endo Pharmaceuticals Holdings (NASDAQ: ENDP), after meeting with the company's senior management to discuss the ENDP acquisition of American Medical Systems. Says Citi, in its report, “The most underappreciated aspects of AMS transaction are its...
-
Jefferies: LLY Q1 Earnings Could Be Under Pressure
Thursday, April 14, 2011 - 8:17am | 140Eli Lilly's (NYSE: LLY) Q1 earnings could be under pressure due to “higher operational costs including the excise fee despite better revenue growth,” Jefferies reports. “We forecast Q1'11E revenues to grow 5.7% (4.2% at CER) to US$5.8bn versus consensus estimate of $5.7bn,” Jefferies writes. “We...
-
Benzinga's Top Pre-Market NASDAQ Gainers (SNTS, NPSP, HGSI, GOLD)
Thursday, April 14, 2011 - 8:12am | 137Santarus Inc (NASDAQ: SNTS) added 2.27% to $3.15 in the pre-market session. SNTS shares have dropped 42.54% over the past 52 weeks, while the S&P 500 index has gained 8.57% in the same period. NPS Pharmaceuticals Inc (NASDAQ: NPSP) moved up 1.41% to $9.37 in the pre-market session. NPSP priced...
-
WCRX Stock Is Ripe, Says Morgan Stanley
Thursday, April 14, 2011 - 7:58am | 153Morgan Stanley, after meeting with Warner Chilcott Plc (NASDAQ: WCRX) CFO Paul Herendeen, says the company is ripe for its current environment. Says Morgan Stanley, in the report, “We believe that WCRX stock is ripe for the current environment because healthcare investors are increasingly focused...